date_range Dauer von 01 von Oktober von 2019 bis 30 von September von 2023 (48 Monate) Fertig

Es wurde auf Konkurrenzfähiger Wettbewerb-Basis gewährt.

Bekanntmachung: INTERREG.18

Forscher/innen

Foto de José Bruno Celso
José Bruno Celso
Fariña Espinosa
Verantwortlich
Foto de María Magdalena
María Magdalena
Echezarreta López
Foto de María Esther
María Esther
Sánchez Sánchez
Foto de Ana María
Ana María
Santoveña Estévez

Publikationen im Zusammenhang mit dem Projekt (10)

Anzeige nach Annuität

Artikel

  1. Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries 2024

    PLoS ONE

  2. A pharmaceutical monitoring system to assess the quality of antituberculosis drug products used in Mauritania 2023

    PLoS ONE

  3. Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis 2022

    Molecules

  4. Monitoring system for substandard detection of antituberculosis drugs used in the Mauritanian National Health System 2021

    RESCIFAR Revista Española de Ciencias Farmacéuticas

  5. Pharmaceutical equivalence and stability study of levofloxacin tablets commercialized in Europe and Africa 2021

    RESCIFAR Revista Española de Ciencias Farmacéuticas

  6. Stability study of isoniazid and rifampicin oral solutions using hydroxypropyl-Β-cyclodextrin to treat tuberculosis in paediatrics 2020

    Pharmaceutics

Konferenz-Beitrag

  1. Quality assessment of antimalarial tablets supplied on the Mauritanian and Spanish markets 2023

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Estudio comparativo del análisis de fármacos antimaláricos con técnicas espectrofotométricas y cromatográficas 2023

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Pharmaceutical equivalence and stability study of levofloxacin tablets commercialized in Europe and Africa 2021

    XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica

  4. Monitoring system for substandard detection of antituberculosis drugs used in the Mauritanian National Health System 2021

    XV Congreso de la Sociedad Española de Farmacia Industrial y Galénica